Your browser doesn't support javascript.
loading
Ebola virus antibody decay-stimulation in a high proportion of survivors.
Adaken, Charlene; Scott, Janet T; Sharma, Raman; Gopal, Robin; Dicks, Steven; Niazi, Saidia; Ijaz, Samreen; Edwards, Tansy; Smith, Catherine C; Cole, Christine P; Kamara, Philip; Kargbo, Osman; Doughty, Heidi A; van Griensven, Johan; Horby, Peter W; Gevao, Sahr M; Sahr, Foday; Dimelow, Richard J; Tedder, Richard S; Semple, Malcolm G; Paxton, William A; Pollakis, Georgios.
Afiliação
  • Adaken C; Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool, UK.
  • Scott JT; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections (HPRU EZI), University of Liverpool, Liverpool, UK.
  • Sharma R; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections (HPRU EZI), University of Liverpool, Liverpool, UK.
  • Gopal R; Faculty of Health and Life Science, University of Liverpool, Liverpool, UK.
  • Dicks S; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
  • Niazi S; Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Ijaz S; High Containment Microbiology, National Infections Service, Public Health England, London, UK.
  • Edwards T; Blood Borne Virus Unit, National Infection Service, Public Health England, London, UK.
  • Smith CC; Transfusion Microbiology, National Health Service Blood and Transplant, London, UK.
  • Cole CP; Blood Borne Virus Unit, National Infection Service, Public Health England, London, UK.
  • Kamara P; Transfusion Microbiology, National Health Service Blood and Transplant, London, UK.
  • Kargbo O; Blood Borne Virus Unit, National Infection Service, Public Health England, London, UK.
  • Doughty HA; Transfusion Microbiology, National Health Service Blood and Transplant, London, UK.
  • van Griensven J; MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, UK.
  • Horby PW; Faculty of Health and Life Science, University of Liverpool, Liverpool, UK.
  • Gevao SM; Travel Medicine and International Health Team, Health Protection Scotland, Glasgow, UK.
  • Sahr F; Oxford Vaccine Group, University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine, Oxford, UK.
  • Dimelow RJ; Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.
  • Tedder RS; National Safe Blood Service, Ministry of Health and Sanitation, Freetown, Sierra Leone.
  • Semple MG; National Safe Blood Service, Ministry of Health and Sanitation, Freetown, Sierra Leone.
  • Paxton WA; National Health Service Blood and Transplant, Birmingham, UK.
  • Pollakis G; College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Nature ; 590(7846): 468-472, 2021 02.
Article em En | MEDLINE | ID: mdl-33505020

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Convalescença / Sobreviventes / Doença pelo Vírus Ebola / Ebolavirus / Anticorpos Antivirais Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: Nature Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Convalescença / Sobreviventes / Doença pelo Vírus Ebola / Ebolavirus / Anticorpos Antivirais Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: Nature Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido